Duration and degree of cyclosporin induced P-glycoprotein inhibition in the rat blood–brain barrier can be studied with PET
- 30 September 2006
- journal article
- Published by Elsevier in NeuroImage
- Vol. 32 (3), 1134-1141
- https://doi.org/10.1016/j.neuroimage.2006.05.047
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Positron Emission Tomography Studies on Binding of Central Nervous System Drugs and P-Glycoprotein Function in the Rodent BrainMolecular Imaging & Biology, 2005
- Quantitative assessment of P-glycoprotein function in the rat blood–brain barrier by distribution volume of [11C]verapamil measured with PETNeuroImage, 2003
- Positron emission tomography microdosing: a new concept with application in tracer and early clinical drug developmentEuropean Journal of Clinical Pharmacology, 2003
- Use of PET and the radioligand [carbonyl-11C]WAY-100635 in psychotropic drug developmentNuclear Medicine and Biology, 2000
- Brain uptake and receptor binding of two [11C]labelled selective high affinity NK1-antagonists, GR203040 and GR205171 — PET studies in rhesus monkeyNeuropharmacology, 2000
- Enhanced cerebral uptake of receptor ligands by modulation of P-glycoprotein function in the blood-brain barrierSynapse, 2000
- Complete in vivo reversal of P‐glycoprotein pump function in the blood‐brain barrier visualized with positron emission tomographyBritish Journal of Pharmacology, 1998
- Rationale for influx enhancement versus efflux blockade to increase drug exposure to the brainBiopharmaceutics & Drug Disposition, 1998
- Comparison of four basic models of indirect pharmacodynamic responsesJournal of Pharmacokinetics and Biopharmaceutics, 1993
- Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.Proceedings of the National Academy of Sciences, 1989